Agios Pharmaceuticals AGIO
NASDAQ AGIO
$32.87 -0.38 (-1.14%)
As of: Oct 1, 2026 · 2:34 PM EDT

Agios Pharmaceuticals (AGIO) Current Deferred Tax Assets (2012 - 2013)

Updated

Agios Pharmaceuticals (AGIO) reported Current Deferred Tax Assets of $1.25 million for Q3 2013, down 0.1% from the prior quarter.

Analysis

Agios Pharmaceuticals (AGIO) Current Deferred Tax Assets (2012 - 2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Agios Pharmaceuticals 1.98 Bn 1.98 Bn 41.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 1.25 Mn
Jun 30, 2013 1.25 Mn
Dec 31, 2012 1.25 Mn
API Access

Agios Pharmaceuticals Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=AGIO&period=max&api_key=YOUR_API_KEY